@article{e01204b618c546d4a21678eaeca3ca26,
title = "The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences",
abstract = "We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.",
author = "Luke, {Douglas A.} and Sarli, {Cathy C.} and Suiter, {Amy M.} and Carothers, {Bobbi J.} and Combs, {Todd B.} and Allen, {Jae L.} and Beers, {Courtney E.} and Evanoff, {Bradley A.}",
note = "Funding Information: Acknowledgments. The authors thank Drs. Ances, Morrissey, and Peipert for their assistance with the TSBM project and providing the data for the case studies. The authors also thank Laura Brossart for assistance with model layout and appearance. The research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. Funding Information: The authors thank Drs. Ances, Morrissey, and Peipert for their assistance with the TSBM project and providing the data for the case studies. The authors also thank Laura Brossart for assistance with model layout and appearance. The research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. D.A.L., C.C.S., A.M.S., B.J.C., T.B.C., J.L.A., C.E.B., and B.A.E. wrote the article. D.A.L., C.C.S., A.M.S., B.J.C., T.B.C., J.L.A., and B.A.E. designed the research. D.A.L., C.C.S., and A.M.S. performed the research. C.C.S. and A.M.S. analyzed the data. Publisher Copyright: {\textcopyright} 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.",
year = "2018",
month = jan,
doi = "10.1111/cts.12495",
language = "English",
volume = "11",
pages = "77--84",
journal = "Clinical and translational science",
issn = "1752-8054",
number = "1",
}